Panacea Biotec Limited (PANACEABIO.NS)

INR 544.6

(-1.37%)

Gross Profit Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual gross profit in 2023 was 1.42 Billion INR , down -31.13% from previous year.
Panacea Biotec Limited's latest quarterly gross profit in 2024 Q1 was 277.7 Million INR , down -29.64% from previous quarter.
Panacea Biotec Limited reported a annual gross profit of 2.07 Billion INR in annual gross profit 2022, down -42.29% from previous year.
Panacea Biotec Limited reported a annual gross profit of 3.59 Billion INR in annual gross profit 2021, down -7.68% from previous year.
Panacea Biotec Limited reported a quarterly gross profit of 1.42 Billion INR for 2023 FY, down -31.13% from previous quarter.
Panacea Biotec Limited reported a quarterly gross profit of 743.3 Million INR for 2023 Q1, up 4.03% from previous quarter.

Annual Gross Profit Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Gross Profit of Panacea Biotec Limited (2023 - 2004)

Year	Gross Profit	Gross Profit Growth
2023	1.42 Billion INR	-31.13%
2022	2.07 Billion INR	-42.29%
2021	3.59 Billion INR	-7.68%
2020	3.89 Billion INR	7.31%
2019	3.62 Billion INR	45.26%
2018	2.49 Billion INR	-33.55%
2017	3.75 Billion INR	1.59%
2016	3.69 Billion INR	-15.44%
2015	4.37 Billion INR	9.85%
2014	3.98 Billion INR	32.08%
2013	3.01 Billion INR	-12.67%
2012	3.45 Billion INR	13.73%
2011	3.03 Billion INR	-50.41%
2010	6.11 Billion INR	-35.62%
2009	9.5 Billion INR	14.02%
2008	8.33 Billion INR	-0.99%
2007	8.41 Billion INR	1.42%
2006	8.3 Billion INR	53.53%
2005	5.4 Billion INR	49.08%
2004	3.62 Billion INR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	277.7 Million INR	-29.64%
2023 FY	1.42 Billion INR	-31.13%
2023 Q1	743.3 Million INR	4.03%
2023 Q2	848.3 Million INR	14.13%
2023 Q3	364.2 Million INR	-57.07%
2023 Q4	394.7 Million INR	8.37%
2022 Q2	686.7 Million INR	27568.0%
2022 Q4	714.5 Million INR	5.98%
2022 FY	2.07 Billion INR	-42.29%
2022 Q1	-2.5 Million INR	-100.79%
2022 Q3	674.2 Million INR	-1.82%
2021 Q4	318.16 Million INR	-70.89%
2021 FY	3.59 Billion INR	-7.68%
2021 Q3	1.09 Billion INR	-14.81%
2021 Q1	898.2 Million INR	14.67%
2021 Q2	1.28 Billion INR	42.83%
2020 FY	3.89 Billion INR	7.31%
2020 Q4	783.26 Million INR	-21.08%
2020 Q3	992.5 Million INR	-16.05%
2020 Q2	1.18 Billion INR	26.68%
2020 Q1	933.2 Million INR	52.6%
2019 Q2	882.9 Million INR	-9.64%
2019 Q3	1.15 Billion INR	30.77%
2019 Q4	611.52 Million INR	-47.04%
2019 FY	3.62 Billion INR	45.26%
2019 Q1	977.1 Million INR	652.37%
2018 Q4	129.87 Million INR	-84.73%
2018 Q2	767.9 Million INR	2.65%
2018 Q1	748.1 Million INR	0.0%
2018 FY	2.49 Billion INR	-33.55%
2018 Q3	850.4 Million INR	10.74%
2017 FY	3.75 Billion INR	1.59%
2016 FY	3.69 Billion INR	-15.44%
2015 FY	4.37 Billion INR	9.85%
2014 FY	3.98 Billion INR	32.08%
2013 FY	3.01 Billion INR	-12.67%
2012 FY	3.45 Billion INR	13.73%
2011 FY	3.03 Billion INR	-50.41%
2010 FY	6.11 Billion INR	-35.62%
2009 FY	9.5 Billion INR	14.02%
2008 FY	8.33 Billion INR	-0.99%
2007 FY	8.41 Billion INR	1.42%
2006 FY	8.3 Billion INR	53.53%
2005 FY	5.4 Billion INR	49.08%
2004 FY	3.62 Billion INR	0.0%

Peer Gross Profit Comparison of Panacea Biotec Limited

Name	Gross Profit	Gross Profit Difference
Biocon Limited	91.73 Billion INR	98.444%
Blue Jet Healthcare Limited	3.15 Billion INR	54.808%
Concord Biotech Limited	7.56 Billion INR	81.126%
Dishman Carbogen Amcis Limited	4.9 Billion INR	70.886%
Jubilant Ingrevia Limited	9.16 Billion INR	84.424%
Lyka Labs Limited	145.95 Million INR	-878.198%
Piramal Pharma Limited	24.47 Billion INR	94.166%
SMS Lifesciences India Limited	329.57 Million INR	-333.193%
Supriya Lifescience Limited	2.65 Billion INR	46.161%
Syngene International Limited	12.43 Billion INR	88.521%
TAKE Solutions Limited	183.42 Million INR	-678.377%
Zota Health Care Limited	332.52 Million INR	-329.349%